Grant C. Bogle

Companies

• Nuvalent, Inc.Board member Dec 9, 2024 to now¹
• Epizyme, Inc.Chief executive officer Aug 16, 2022 to Aug 16, 2022²
• Epizyme, Inc.President Aug 16, 2022 to Aug 16, 2022²
• Epizyme, Inc.Board member Sep 4, 2019 to Aug 16, 2022³
• Epizyme, Inc.Officer Aug 18, 2021 to Aug 11, 2022⁴
• TesaroSVP & Chief Commercial Officer Jul 14, 2015 to Jan 22, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EEpizyme, Inc.0 shares⁶Aug 12, 2022
• NNuvalent, Inc.0 shares⁷Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 5,577 shares of Nuvalent, Inc.⁷
• Jul 15, 2026U 3,714 shares at $124.00 of Nuvalent, Inc.⁷
• Jun 16, 2026Granted 3,444 shares of Nuvalent, Inc.⁸
• Jun 18, 2025Granted 2,647 shares of Nuvalent, Inc.⁹
• Dec 5, 2024Granted 3,200 shares of Nuvalent, Inc.¹⁰
• Aug 12, 2022Returned to company 175,000 shares of Epizyme, Inc.⁶
• Aug 12, 2022Returned to company 84,170 shares of Epizyme, Inc.⁶
• Aug 9, 2022Shares withheld for tax 395,083 shares at $1.41 of Epizyme, Inc.¹¹
• Aug 9, 2022Exercised options 417,500 shares at $1.41 of Epizyme, Inc.¹¹
• Aug 9, 2022Shares withheld for tax 746,307 shares at $1.39 of Epizyme, Inc.¹¹
• Aug 9, 2022Exercised options 800,000 shares at $1.39 of Epizyme, Inc.¹¹
• Feb 2, 2022Granted 87,500 shares of Epizyme, Inc.¹²